You are here » Home » Companies » Company Overview » Glaxosmithkline Pharmaceuticals Ltd

Glaxosmithkline Pharmaceuticals Ltd.

BSE: 500660 Sector: Health care
NSE: GLAXO ISIN Code: INE159A01016
BSE 00:00 | 19 Nov 1640.50 13.55
(0.83%)
OPEN

1638.00

HIGH

1671.00

LOW

1630.10

NSE 00:00 | 19 Nov 1639.85 11.45
(0.70%)
OPEN

1635.00

HIGH

1670.30

LOW

1626.10

OPEN 1638.00
PREVIOUS CLOSE 1626.95
VOLUME 4604
52-Week high 1699.95
52-Week low 1131.05
P/E 56.26
Mkt Cap.(Rs cr) 27,792
Buy Price 1630.00
Buy Qty 25.00
Sell Price 1640.50
Sell Qty 299.00
OPEN 1638.00
CLOSE 1626.95
VOLUME 4604
52-Week high 1699.95
52-Week low 1131.05
P/E 56.26
Mkt Cap.(Rs cr) 27,792
Buy Price 1630.00
Buy Qty 25.00
Sell Price 1640.50
Sell Qty 299.00

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) - Corporate Action

Search Purpose:
From: To:
ANNOUNCEMENT DATE PURPOSE REMARKS
22-10-2019 Board Meeting GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of...
22-07-2019 Board Meeting GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of...
20-05-2019 Board Meeting GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of...
04-02-2019 Board Meeting We wish to inform you that the in terms of the provisions of SEBI (Prohi...
22-10-2018 Board Meeting GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of...
24-07-2018 Board Meeting Quarterly Results
24-05-2018 Board Meeting We wish to inform you that the in terms of the provisions of SEBI (Prohi...
02-02-2018 Board Meeting We wish to inform you that the in terms of the provisions of SEBI (Prohi...
25-10-2017 Board Meeting We wish to inform you that the in terms of the provisions of SEBI (Prohi...
25-07-2017 Board Meeting Quarterly Results
19-05-2017 Board Meeting Dear Sir, Sub: Closure of 'Trading Window' We wish to inform you that th...
11-02-2017 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that in terms of th...
27-10-2016 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the in terms o...
28-07-2016 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that in terms of th...
25-05-2016 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the in terms o...
10-02-2016 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the restricted...
31-10-2015 Board Meeting Quarterly ResultsGlaxoSmithKline Pharmaceuticals Ltd has informed BSE th...
31-07-2015 Board Meeting Quarterly ResultsGlaxoSmithKline Pharmaceuticals Ltd has informed BSE th...
18-05-2015 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
08-05-2015 Board Meeting Dividend & Audited Results
12-02-2015 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
06-11-2014 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
12-08-2014 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
17-04-2014 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
18-02-2014 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
11-11-2013 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
07-08-2013 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
07-05-2013 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...
19-02-2013 Board Meeting GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t...